Transplantation News

Hospitals that performed at least 25 major hepatectomies per year had lower rates of postoperative in-hospital mortality and failure to rescue, suggesting better management of postoperative complications.

The Cleveland Clinic reached an institutional milestone in 2022, with 1,050 heart, kidney, liver, intestine and lung transplants, surpassing its previous record high set in 2021, according to a press release.

Physical frailty before liver transplant correlated with poor functional status and health-related quality of life 1 year after surgery among patients with cirrhosis, according to research published in JAMA Surgery.

CHARLOTTE, N.C. — A subgroup analysis of liver transplant patients with hepatorenal syndrome type 1 demonstrated that terlipressin decreased the need for renal replacement therapy up to 12 months following transplantation.

WASHINGTON — Fewer Black and Hispanic patients received curative treatment for early-stage hepatocellular carcinoma compared with white patients, according to research presented at The Liver Meeting.

WASHINGTON — Patients with cirrhosis in low- or middle-income countries had an increased risk for inpatient and 30-day mortality, likely due to disparities in transplant access, according to research presented at The Liver Meeting.

WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score greater than 25 compared with those with lower MELD scores, according to data presented at The Liver Meeting.

WASHINGTON — The MELD score at transplant minus three points policy led to poor survival and recurrence outcomes after liver transplantation among patients with hepatocellular carcinoma, according to research at The Liver Meeting.

WASHINGTON — The Multi-Organ Dysfunction and Evaluation for Liver transplantation, or MODEL, score predicted high probability of mortality in transplant patients with severe acute-on-chronic liver failure, according to research.

WASHINGTON — MELD 3.0 more accurately predicted the risk for 90-day waitlist mortality compared with MELD-Na among adolescent patients on a liver transplant waitlist, according to research presented at The Liver Meeting.